首页> 外文会议>International Congress on Coronary Artery Disease >Novel G Protein-Coupled Receptor Signalling Pathways in Cardiac Hypertrophy
【24h】

Novel G Protein-Coupled Receptor Signalling Pathways in Cardiac Hypertrophy

机译:新型G蛋白偶联受体信号传导途径在心脏肥大

获取原文

摘要

In this presentation, we discuss two novel signaling pathways involving cardiac GPCR. Gq-coupled GPCR for catecholamines or angiotensin are very important in cardiovascular function and dysfunction. ERK5, a member of the MAPK family, has recently been shown to be involved in cardiac hypertrophy and to be stimulated by Galphaq-coupled GPCR via unknown mechanisms. We identify the atypical PKCxi as the functional link between these two key players in cardiovascular signaling and show that this novel Gaq/PKCxi axis is required for angiotensin-induce hypertrophy in mice. On the other hand, antibodies specific for the beta_1-adrenergic receptor (beta_1AR) are highly prevalent in patients with idiopathic dilated cardiomyopathy (DCM). We find that human beta_1AR - autoantibodies potently stimulate ERK1/2 in cardiac cells by using signalling pathways different from those triggered by classic beta-agonists. Our results suggest that these antibodies elicit a distinct beta_1AR active conformation leading to the engagement of signaling effectors different from those recruited by classic beta-agonists.
机译:在本文中,我们讨论了两种涉及心脏GPCR的新型信号通路。用于儿茶酚胺或血管紧张素的GQ偶联GPCR在心血管功能和功能障碍中非常重要。 MAPK系列成员ERK5最近被证明参与心脏肥大,并通过GALPHAQ偶联GPCR通过未知机制刺激。我们将非典型PKCXI识别为心血管信令中这两个关键球员之间的功能链接,并表明小鼠血管紧张素诱导肥大需要该新型GAQ / PKCXI轴。另一方面,特征性扩张心肌病(DCM)患者对β-肾上腺素能受体(BETA_1AR)特异的抗体高度普遍。我们发现人体Beta_1ar - 自身抗体通过使用经典β-激动剂触发的信号通路效果刺激心脏细胞中的ERK1 / 2。我们的研究结果表明,这些抗体引起了明显的β1AR主动构象,导致信号效应与经典β-激动剂招募的信号效应的接合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号